Found: 31
Select item for more details and to access through your institution.
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles.
- Published in:
- Archives of Gynecology & Obstetrics, 2010, v. 282, n. 2, p. 207, doi. 10.1007/s00404-010-1432-2
- By:
- Publication type:
- Article
Erratum to "Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer".
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/6153432
- By:
- Publication type:
- Article
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/2715968
- By:
- Publication type:
- Article
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2055, doi. 10.3390/ijms24032055
- By:
- Publication type:
- Article
Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8467, doi. 10.3390/ijms21228467
- By:
- Publication type:
- Article
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1618, doi. 10.3390/ijms17101618
- By:
- Publication type:
- Article
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
- Published in:
- Scientific Reports, 2016, p. 20484, doi. 10.1038/srep20484
- By:
- Publication type:
- Article
Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique.
- Published in:
- 2016
- By:
- Publication type:
- journal article
RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 5, p. 1091, doi. 10.1002/1878-0261.13135
- By:
- Publication type:
- Article
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells.
- Published in:
- Liver International, 2017, v. 37, n. 1, p. 80, doi. 10.1111/liv.13183
- By:
- Publication type:
- Article
Focal adhesion kinase activation limits efficacy of Dasatinib in c‐Myc driven hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 12, p. 6170, doi. 10.1002/cam4.1777
- By:
- Publication type:
- Article
Functional role of SGK3 in PI3K/Pten driven liver tumor development.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 2, p. 1, doi. 10.1038/s41419-019-1389-4
- By:
- Publication type:
- Article
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 2, p. 1, doi. 10.1038/s41419-017-0183-4
- By:
- Publication type:
- Article
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03177-7
- By:
- Publication type:
- Article
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges.
- Published in:
- Biomedicines, 2024, v. 13, n. 7, p. 1624, doi. 10.3390/biomedicines12071624
- By:
- Publication type:
- Article
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism.
- Published in:
- Molecules, 2020, v. 25, n. 18, p. 4141, doi. 10.3390/molecules25184141
- By:
- Publication type:
- Article
Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Fine Structure of Glycosaminoglycans from Fresh and Decellularized Porcine Cardiac Valves and Pericardium.
- Published in:
- Biotechnology Research International, 2012, p. 1, doi. 10.1155/2012/979351
- By:
- Publication type:
- Article
Association between Human Plasma Chondroitin Sulfate Isomers and Carotid Atherosclerotic Plaques.
- Published in:
- Biotechnology Research International, 2012, p. 1, doi. 10.1155/2012/281284
- By:
- Publication type:
- Article
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02394-2
- By:
- Publication type:
- Article
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02283-8
- By:
- Publication type:
- Article
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27 KIP1 Regulation.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 7, p. 1160, doi. 10.3390/medicina60071160
- By:
- Publication type:
- Article
Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01412
- By:
- Publication type:
- Article
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0184068
- By:
- Publication type:
- Article